AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2006
Dec 19, 2006
30339_dirs_2006-12-19_01bb0def-e0f0-4748-b641-2c255f4cdc30.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-12-15
Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-12-15 | Common Stock | A | 15.25 | $51.0900 | Acquired | 14945.8830 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 190550.2625 | Direct |
| Common Stock | 782.8102 | Indirect |
Footnotes
F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27